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ABSTRAK 
 
Background: Sydenham chorea is an involuntary 
movement disorder due to an autoimmune process. It 
may be part of rheumatic fever symptoms. A thorough 
and complete examination is needed to create the right 
diagnose. It will support the success of therapy and 
prevent other complications. 
Case: An 18-year-old woman went to the hospital 
with complaints of involuntary movement on the left 
side accompanied by fever, breathing problems, and 
nausea. There were no motoric weakness, tremor or 
another involuntary movement. Laboratory blood 
results for Anti Streptolysin Titer O (ASTO) and C-
Reactive Protein (CRP) results increased. The 
cardiologist confirmed she had mild mitral valve 
regurgitation. Those exams results were part of the 
criteria for diagnosing rheumatic fever, and the patient 
can get the right therapy immediately 
Discussion: Sydenham Chorea can’t threaten the 
patient’s life directly, but incorrect examination and 
treatment will cause other severe complications. That 
is because Chorea Sydenham is part of the 
autoimmune process, which can cause the other organs 
complication. 
Conclusion: Sydenham Chorea may relate to 
rheumatic fever. Early diagnostic is essential and it 
will support the provision of therapy and accelerate the 
recovery of patients.
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 Background 
Involuntary movement is a spontaneous 
movement that is uncontrollable, unconscious, 
aimless, unpredictable at any time and not 
controlled or stopped when the person moves and 
disappears during sleep time. There are several 
types of involuntary movement disorders. Chorea 
is one type of involuntary movement disorder 
caused by a disturbance in the part of the brain 
called the basal ganglia, precisely in the caudate 
nucleus of the corpus striatum. Chorea comes 
from the Greek "Chorea" which means dancing. 
As the name implies, the characteristics of the 
chorea movement resemble in a dancing. The 
movements are not synchronizing to each other; 
they are strong, fast, and jerked, while the 
direction of movement changes quickly. There are 
several types of chorea including Huntington 
chorea (major chorea) caused by hereditary 
factors, chorea due to metabolic disorders such as 
Wilson disease, idiopathic chorea such as 
physiological chorea in infants, and Sydenham 
chorea (chorea minor) caused by autoimmune 
disorders of the body.1  
In Sydenham chorea, the involuntary movements 
symptoms started by bacterial infection of 
Haemolytic Streptococcus Beta A Group. The 
bacterial infection manifested around six months 
earlier before the involuntary movement symptom 
appears on the patient. Some data show that post-
streptococcal infection might manifest into other 
extrapyramidal movement disorders such as 
dystonia, tic, tremor, but Sydenham chorea is 
specifically found most commonly on the patient 
with rheumatic fever. This symptom is part of 
rheumatic fever disease. Sydenham chorea attacks 
women more often than men with a ratio of 3:1 
and more often appears on children around 5-15 
years old.2  
Unfortunately, there is no exact number about the 
Sydenham chorea incident in Indonesia yet. There 
is some proof that in developing countries, the 
incidence of rheumatic fever is higher due to poor 
sanitation compared to developed countries.3 
Those involuntary movements can appear on the 
face, arms, or lower limbs. Involuntary 
movements that arise during an attack can be 
repeated from several minutes to hours, either 
with a resting interval between movements or 
continuously. It is common for patients to 
experience pain or fatigue due to repeated 
movements uncontrollably. Aside from chorea, 
rheumatic fever can also manifest in ballistic 
movement due to damage of other parts in basal 
ganglia, meningeal irritation, encephalomyelitis, 
and optic neuritis.4  
Other symptoms commonly complained include 
fever, shortness of breath due to abnormalities in 
the heart valves, weakness and pain in the limbs. 
Those are mainly caused by the inflammation of 
the organs due to the infection process caused by 
Streptococcus. To deal with abnormalities of 
Sydenham chorea, a comprehensive and complete 
examination is required. This step is needed to 
create a proper diagnosis and will support the 
success of therapy. The goal of therapy is not only 
to overcome the symptoms of involuntary motion 
disorders but also to eliminate the main causes, 
overcome additional symptoms, and prevent other 
severe complications. Therefore, sometimes 
treatment and teamwork of several specialists are 
needed so the diagnosis can be properly made. 
When those are accomplished, the therapy can be 
administered to the patients as soon as possible.5 
Some laboratory blood tests such as erythrocyte 
sedimentation rate and C-reactive protein are 
needed to determine whether there is an 
inflammatory process and to know the existence 
of the previous infection. Another useful 
examination to determine the presence of 
Haemolytic Streptococcus Beta A Group bacterial 
infection previously was the Anti Streptolysin O 
(ASTO) blood examination. There is a precaution 
that 20% of Sydenham chorea patients have no 
serological evidence of previous Streptococcus 
infection.3  
ECG or echocardiography is needed to check if 
there is a rheumatic fever disorder that affects the 
part of the heart, although not every patient might 
experience it. The principle of therapy in 
Sydenham chorea itself is by giving penicillin 
group antibiotics, or erythromycin and anti-
inflammatory groups to eliminate the etiology of 
streptococcal bacterial infection. If complications 
are found in the heart valve, it is recommended to 
immediately request further treatment from the 
cardiologist. Whereas the involuntary movement 
abnormalities can be medicated by antipsychotic 
drugs which function as dopamine antagonists and 
have the effect of being anti-spasmodic to control 
abnormal movements.  
This case report provides information about the 
symptoms of Sydenham chorea, which is 
sometimes forgotten as part of the symptoms of 
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 rheumatic fever. Understanding the symptoms of 
Sydenham chorea and rheumatic fever can lead to 
an earlier establishment of the diagnosis. This 
information will be useful to provide appropriate 
management in patients with Sydenham chorea 
and can avoid further complications from 
rheumatic fever. 
 
Case Illustration 
An 18-year-old young woman was sent to the ER 
of Wangaya Regional Hospital with the main 
complaint of the left side of the body moved 
uncontrollably and can’t be stopped for the last 
three days. In the beginning, these movements 
only appear a few minutes every few hours. As 
time goes, the duration is getting longer, and the 
frequency increases more often. Those symptoms 
were causing discomfort and disrupting the 
patient's activity. When the patient came to the 
hospital for treatment, she was still experiencing 
involuntary movements that occur in parts of the 
body covering the neck area, up to the left arm. 
The movements are slow, repetitive, swinging, 
similar to the movement of a dancer, which occur 
unnoticed and cannot be controlled. The duration 
of movement happening from 5-10 minutes to 
each attack and reappears several times. There is 
a break between several attacks when no 
involuntary movement is happening. The patient 
also experienced other symptoms such as fever, 
shortness of breath, nausea, and muscle pain 
(arthralgia) due to repetitive involuntary 
movement. In the past nine months, there was a 
history of repetitive rhinitis and pharyngitis. 
Patients claimed there had been no previous 
history of a similar disease and no history of 
seizures in either the patient or family. The patient 
also denied using other drugs as medication. 
During the examination, the patient had full 
awareness. The consciousness level was Compos 
Mentis with GCS score E4V5M6, and had 
adequate contact. The patient was moderately ill, 
with a body temperature of 38.50C, blood 
pressure 130/80 mmHg, respiratory rate 30x / 
minute, pulse frequency 110x / minute, 99% 
oxygen saturation. The neurological examination 
results consisted of isochore pupils with positive 
bilateral light reflex, no meningeal signs were 
found. There were no weaknesses and 
lateralization. The results of motor and muscle 
tone examination were within normal limits. No 
pathological reflex was found. No other 
involuntary movements such as hemiballismus, 
athetosis or tremor were found. Laboratory tests 
carried out in the form of routine blood with 
leukocyte results: 15.46 / ul, neutrophils: 71, 5%, 
lymphocytes: 15.1%, monocytes: 13.1%. 
Examination of the chest x-ray on anterior-
posterior position showed the result of the heart, 
lung, pleura, and diaphragm were in normal 
condition. On Echocardiography examination, 
there was a sinus tachycardia rhythm. During the 
patient stay at the hospital, other blood tests were 
being examined. Those tests were Anti-
Streptolysin Titer O (ASTO), and C-Reactive 
Protein (CRP) with ASTO results: 450 IU / mL 
and CRP: 4.5 mg / L. The neurologist gave 
medication of antipsychotic therapy which 
functions as an anti-spasm to reduce involuntary 
movements. The chosen drug was haloperidol 
tablet 2x5 mg, and diazepam tablet 2x5 mg if the 
involuntary movement symptoms not showing 
any improvement.  The neurologist then consults 
the patient to get further examination and 
treatment from a cardiologist. Echocardiography 
was performed by a cardiologist, and mild mitral 
regurgitation was found. Treatments for this 
abnormality are acetosal tablet 3x500mg, and 
benzathine Penicillin 1.2 million IU IM per 
injection for two days. For other additional 
symptoms, the patient has to take paracetamol 
tablets 3x500 mg to treat the fever. The injection 
of Proton Pump Inhibitor (PPI) class drug was 
administered to prevent stomach irritation and 
reduce nausea. After the third day of treatment, 
the patient condition had improved, and she 
experienced less involuntary movements in the 
left part of her. The patient also experienced fewer 
symptoms of fever, nausea and shortness of 
breath. The dose of haloperidol is reduced to 
3x2.5 mg (1/2 tablet) orally and maintained until 
home. The patient returned home on the 6th day 
and had planned to control her condition at the 
neurology clinic five days after leaving the 
hospital. The patient was also got advice to take 
head CT-scan examination when she visited the 
neurology clinic if there were going to be any 
other neurological symptoms during her stay at 
home. 
Discussion 
Sydenham chorea is a neurological manifestation 
of rheumatic fever and occurs 20-40% in patient 
with rheumatic fever. It was caused by the 
infection of Haemolytic Streptococcus Group A 
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 bacteria. During the infection, the patient's body 
forms immunoglobulin G antibodies which 
reacting to cross the Streptococcus membrane 
antigens and cells in the neuronal cytoplasm of the 
caudate nucleus and subthalamic nucleus 
(intracellular tubulin and extracellular 
lysoganglioside). This process happens because 
the antigens from Streptococcus bacteria 
molecularly in the patient's body disguise 
themselves so that they are similar to the cells 
found in the cytoplasmic wall of the basal ganglia, 
especially the caudate nucleus (this process is also 
called mimicry). This cause the host antibody not 
only attack antigens from Streptococcus bacteria 
but also contributes to damage to basal ganglia 
cells because the host antibodies cannot 
distinguish between the original bacterial antigen 
and the basal ganglia cell wall which has been 
modified by Streptococcus bacterial antigens. As 
a result of damage to the basal ganglia cell wall, 
its function is to control and change the 
movements of rough movements to be smooth and 
regular also damaged. This movement 
abnormality is a neurological manifestation of 
rheumatic fever.6 
It is only one part of an autoimmune disease 
caused by bacterial infection with Haemolytic 
Streptococcus Group A. Rheumatic fever is a 
collection of some abnormality that appears due to 
this autoimmune process. The Streptococcus 
antigen is also reported to have similarities to the 
structure on the muscle fibers of the heart wall 
organ. That causes the abnormalities in the heart 
is also a frequent manifestation.7  
Diagnosing Sydenham chorea is not enough just 
by having a physical examination or a brief 
history. A thorough anamnesis is needed, 
including the history of the patient's illness to the 
symptoms of other diseases and the 
accompanying complications. To be able to 
diagnose rheumatic fever, the latest 2015 Jones 
criteria used by the AHA are used. It is said that 
the patient meets the criteria for rheumatic fever 
when there are two major criteria or one major 
criterion plus two minor criteria from the 
classification of rheumatic fever by Jones. There 
are three major criteria, and three minor criteria of 
Jones diagnosis criteria can be found on the 
patient which are appropriate for rheumatic fever 
diagnosis. The major criteria found in this patient 
are the presence of subclinical carditis where 
cardiac abnormalities are found on 
echocardiography in the form of mild mitral 
regurgitation. Physical examination revealed 
tachycardia with shortness of breath in the initial 
complaint. And for the second major criteria is the 
presence of Sydenham chorea itself. Whereas for 
the two minor criteria in this patient were the 
symptoms of fever with the results of ASTO blood 
laboratory tests: 400 IU / mL and CRP patients 
with 4.5 mg/dl where both values experienced an 
increase. The patient also experienced muscle 
pain (polyarthralgia) caused by the rapid 
involuntary movement. These symptoms have 
met the diagnostic criteria for rheumatic fever 
according to the latest revised Jones classification 
in 2015. (table 1). Another supporting factor is the 
female gender of the patient, where the female sex 
has a high incidence of Sydenham chorea in 
rheumatic fever. Even though the patient's age is 
over 15 years, it does not rule out the diagnosis 
possibility of rheumatic fever. The diagnose of 
rheumatic fever for this patient is supported by the 
symptoms and previous history of respiratory tract 
infection, which are matching the Jones criteria 
for rheumatic fever.8 The symptoms of cardiac 
abnormalities in the patient are only mild, which 
is the presence of tachycardia and mild tightness. 
But to ensure there is no further complication in 
the heart organ, the patient must go through 
several examinations on the second day of 
treatment. Those are among others an 
echocardiography, electrocardiography(ECG), 
and chest X-ray. From the chest X-ray, no 
abnormality was found, and there was only a sinus 
rhythm tachycardia on the ECG results. On 
echocardiography examination, there was mild 
mitral regurgitation due to an autoimmune process 
caused by bacterial infection of Haemolytic 
Streptococcus Group A which caused 
inflammation in the heart area.9 Other supportive 
examinations such as CT scan or MRI were not 
performed because they usually did not produce 
significant results in Sydenham chorea patient 
with rheumatic fever and the patient was not 
showing any other neurological abnormalities.10 
The patient is still given the advice to take head 
CT-Scan examination during her visit to the 
neurology policlinic if she had any other 
neurological symptoms.  
The medication she took was for eliminating the 
infection of the Haemolytic Streptococcus group 
A which is the etiology of the autoimmune 
process itself. The therapy was in the form of 
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 penicillin class antibiotics, namely benzathine 
penicillin at a dose of 1.2 million IU IM 
injection/day, administered for two days. Other 
antibiotic choices to treat Haemolytic 
Streptococcus Group A infections is azithromycin 
with the dose of 500 mg once daily for 5-7 days or 
clarithromycin 2x250 mg each day for 10 days. 
The treatment for the symptoms of involuntary 
movement was neuroleptic drugs. The chosen 
drug therapy is haloperidol. It’s working against 
chorea by inhibiting the effect of dopamine and 
increasing its turnover. Dopamine is a 
neurotransmitter, a signaling molecule in the brain 
which is involved in motor control. The increased 
activity of dopamine is thought to cause chorea. 
The exact mechanism is not yet fully understood 
but it is thought to block so-called dopamine D2 
receptors. This prevents dopamine from binding 
to receptors, which interfering with dopamine’s 
action in the result, and it will control abnormal 
movements in the end. The dose given on the 
therapy is 2x5mg tablets. In addition, the patient 
was also given diazepam with a dose of 2x5 mg 
given which was only used on the first day of 
treatment because the patient already shows 
improvement after given the previous drug. 
Diazepam is a benzodiazepine class of drugs that 
used to increase levels of GABA concentration in 
cauda, putamen, substantia nigra, and globus 
pallidus. By analogy with increased GABA 
activity can reduce chorea movement. Usually 
given as adjuvant therapy. The mild 
manifestations of the patient's heart were treated 
by using aspirin. The use of aspirin is intended as 
a non-steroid anti-inflammatory to deal with 
damage to the heart organs due to streptococcus 
infections. The recommended dose is 100 mg/kg 
which is divided into 4 doses per day, but the high 
dose is feared to give negative side effects to the 
patient's gastrointestinal tract so that the 
administration drug dose is adjusted to 3 x 500 mg 
tablet. Non-steroid anti-inflammation drugs are a 
better option for treating carditis rather than a 
steroid one. That’s because non-steroid anti-
inflammation drugs can be used continuously 
without having to taper off the dose when the 
therapy has to stop. Anti-inflammation drugs can 
be used for 2-4 weeks, depending on the clinical 
progress. The patient was also medicated by using 
Proton Pump Inhibitor (PPI) drugs to reduce 
nausea and reduce the risk of stomach irritation. 
Paracetamol 3x500mg tablet was given to reduce 
fever. Prophylaxis treatment can be given for 
young patients around 3-15 years old who have 
resistant symptoms or recurrent infection of 
Streptococcus.  
The chosen prevention therapy is the continuous 
injection of benzathine G penicillin 1.2 million 
units every 3-4 weeks. The other oral antibiotics 
used as prophylaxis isn’t as effective.  
But this prevention might different for each 
patient because of the inconvenience of frequent 
injection.1 
The early diagnosis is very important because it 
will affect the administration of therapy. 
Sydenham chorea does not directly threaten life 
immediately, but other symptoms of rheumatic 
fever can have a fatal effect on the patient. The 
complication which might appear due to 
mistreated and misdiagnosis are permanent 
damage to basal ganglia which can cause 
untreated involuntary movement and worsening 
the muscle spasm. Another severe complication is 
heart failure due to further damage to heart tissue 
which can cause death. Sydenham chorea in this 
patient appears because it is part of rheumatic 
fever symptoms so that the treatment is not 
separated only from medication to stop the 
symptoms of involuntary motion alone. With the 
right diagnosis and early treatment, the symptoms 
of the patient's illness gradually reduced and other 
severe complications can be avoided. The patient 
is taking advice to maintain hygiene for 
preventing recurrent upper respiratory tract 
infections which can cause repetitive infections 
and can manifest again into rheumatic fever.12 
 
 
 
Table 1. Jones criteria for rheumatic fever (revised 2015) and Patient’s condition and symptoms 
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Conclussion 
Sydenham Chorea is an involuntary movement 
disorder that can be part of rheumatic fever 
symptoms. It may attack young adult who has 
recurrent upper respiratory tract infections in the 
last six months, the presence of fever, and the 
appearance of abnormalities in the heart. When 
the patient can get treatment immediately, it will 
reduce the risk of other severe complications such 
as permanent damage to basal ganglia and cardiac 
heart muscle.
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